[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  IQBAL [@Muhammed_iq_bal](/creator/twitter/Muhammed_iq_bal) on x 1535 followers Created: 2025-07-21 16:30:54 UTC 🚀 Glenmark's innovation pipeline looks promising! 🔹 Ryaltris (respiratory) - already launched globally 🔹 Jabryus (dermatology) - launched in India 🔹 Winlevi (dermatology) - FY26 launch in Europe/UK/SA 🔹 Tevimbra (oncology) - launched in India 🔹 QiNHAYO (oncology) - FY27 launch in India/EM 📢 Peak sales target: $350-400M over 5-7 years! #Pharma  XXX engagements  **Related Topics** [$350400m](/topic/$350400m) [india](/topic/india) [dermatology](/topic/dermatology) [Post Link](https://x.com/Muhammed_iq_bal/status/1947333474526040335)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
IQBAL @Muhammed_iq_bal on x 1535 followers
Created: 2025-07-21 16:30:54 UTC
🚀 Glenmark's innovation pipeline looks promising!
🔹 Ryaltris (respiratory) - already launched globally 🔹 Jabryus (dermatology) - launched in India 🔹 Winlevi (dermatology) - FY26 launch in Europe/UK/SA 🔹 Tevimbra (oncology) - launched in India 🔹 QiNHAYO (oncology) - FY27 launch in India/EM
📢 Peak sales target: $350-400M over 5-7 years!
#Pharma
XXX engagements
Related Topics $350400m india dermatology
/post/tweet::1947333474526040335